Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Musset

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Radiology|September 1, 1986
Primary lung cancer staging: prospective comparative study of MR imaging with CTD Musset, P Grenier, M F Carette, et al.
Presse Medicale (Paris, France : 1983)|November 23, 2005
[Surgical treatment of chronic thromboembolic pulmonary hypertension]P Dartevelle, E Fadel, S Mussot, et al.
Revue Des Maladies Respiratoires|May 1, 2007
[Postembolic pulmonary hypertension]X Jais, P Dartevelle, F Parent, et al.
Annals of Internal Medicine|February 15, 2001
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic diseaseG Merli, T E Spiro, C G Olsson, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Radiology|September 1, 1986
Primary lung cancer staging: prospective comparative study of MR imaging with CTD Musset, P Grenier, M F Carette, et al.
Presse Medicale (Paris, France : 1983)|November 23, 2005
[Surgical treatment of chronic thromboembolic pulmonary hypertension]P Dartevelle, E Fadel, S Mussot, et al.
Revue Des Maladies Respiratoires|May 1, 2007
[Postembolic pulmonary hypertension]X Jais, P Dartevelle, F Parent, et al.
Annals of Internal Medicine|February 15, 2001
Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic diseaseG Merli, T E Spiro, C G Olsson, et al.
Pageof 8